{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T02:48:42Z","timestamp":1787194122057,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Popul Health Metrics"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12963-017-0123-7","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T07:20:12Z","timestamp":1487316012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963\u20132014)"],"prefix":"10.1186","volume":"15","author":[{"given":"Mangalee R.","family":"Fernando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Dent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopala K.","family":"Rangan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,17]]},"reference":[{"key":"123_CR1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0272-6386(83)80044-4","volume":"2","author":"CG Iglesias","year":"1983","unstructured":"Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935\u20131980. Am J Kidney Dis. 1983;2:630\u20139.","journal-title":"Am J Kidney Dis"},{"key":"123_CR2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/jmg.24.8.474","volume":"24","author":"H Kaariainen","year":"1987","unstructured":"Kaariainen H. Polycystic kidney disease in children: a genetic and epidemiological study of 82 Finnish patients. J Med Genet. 1987;24:474\u201381.","journal-title":"J Med Genet"},{"key":"123_CR3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5414\/CNP57208","volume":"57","author":"KC Abbott","year":"2002","unstructured":"Abbott KC, Agodoa LY. Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol. 2002;57:208\u201314.","journal-title":"Clin Nephrol"},{"key":"123_CR4","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","volume":"7","author":"JJ Grantham","year":"2011","unstructured":"Grantham JJ, Mulamalla S, Swenson-Fields KI. Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2011;7:556\u201366.","journal-title":"Nat Rev Nephrol"},{"key":"123_CR5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5414\/CNP72259","volume":"72","author":"V Corradi","year":"2009","unstructured":"Corradi V, Gastaldon F, Virzi GM, de Cal M, Soni S, Chionh C, Cruz DN, Clementi M, Ronco C. Clinical pattern of adult polycystic kidney disease in a northeastern region of Italy. Clin Nephrol. 2009;72:259\u201367.","journal-title":"Clin Nephrol"},{"key":"123_CR6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.semnephrol.2015.10.002","volume":"35","author":"GK Rangan","year":"2015","unstructured":"Rangan GK, Lopez-Vargas P, Nankivell BJ, Tchan M, Tong A, Tunnicliffe DJ, Savige J. Autosomal dominant polycystic kidney disease: a path forward. Semin Nephrol. 2015;35:524\u201337.","journal-title":"Semin Nephrol"},{"key":"123_CR7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrneph.2010.18","volume":"6","author":"PC Harris","year":"2010","unstructured":"Harris PC, Rossetti S. Molecular diagnostics for autosomal dominant polycystic kidney disease. Nat Rev Nephrol. 2010;6:197\u2013206.","journal-title":"Nat Rev Nephrol"},{"key":"123_CR8","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/ajkd.2001.27720","volume":"38","author":"RD Perrone","year":"2001","unstructured":"Perrone RD, Ruthazer R, Terrin NC. Survival after end-stage renal disease in autosomal dominant polycystic kidney disease: contribution of extrarenal complications to mortality. Am J Kidney Dis. 2001;38:777\u201384.","journal-title":"Am J Kidney Dis"},{"key":"123_CR9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.ackd.2009.12.006","volume":"17","author":"A Alam","year":"2010","unstructured":"Alam A, Perrone RD. Management of ESRD in patients with autosomal dominant polycystic kidney disease. Adv Chronic Kidney Dis. 2010;17:164\u201372.","journal-title":"Adv Chronic Kidney Dis"},{"key":"123_CR10","first-page":"755","volume":"26","author":"PW Lee","year":"2012","unstructured":"Lee PW, Chien CC, Yang WC, Wang JJ, Lin CC. Epidemiology and mortality in dialysis patients with and without polycystic kidney disease: a national study in Taiwan. J Nephrol. 2012;26:755\u201362.","journal-title":"J Nephrol"},{"key":"123_CR11","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2215\/CJN.01460210","volume":"5","author":"B Orskov","year":"2010","unstructured":"Orskov B, Romming Sorensen V, Feldt-Rasmussen B, Strandgaard S. Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark. Clin J Am Soc Nephrol. 2010;5:2034\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"key":"123_CR12","doi-asserted-by":"crossref","first-page":"691A","DOI":"10.1681\/ASN.2013030295","volume":"24","author":"E Spithoven","year":"2013","unstructured":"Spithoven E, Kramer A, Wanner C, Jager KJ, Gansevoort RT. Incidence of renal replacement therapy in Europe. J Am Soc Nephrol. 2013;24:691A.","journal-title":"J Am Soc Nephrol"},{"key":"123_CR13","doi-asserted-by":"crossref","first-page":"832 e837","DOI":"10.1016\/j.amjmed.2012.12.018","volume":"126","author":"I Helal","year":"2013","unstructured":"Helal I, McFann K, Reed B, Yan XD, Schrier RW. Changing referral characteristics of patients with autosomal dominant polycystic kidney disease. Am J Med. 2013;126:832 e837\u201311.","journal-title":"Am J Med"},{"key":"123_CR14","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.08350813","volume":"9","author":"MA Cadnapaphornchai","year":"2014","unstructured":"Cadnapaphornchai MA, George DM, McFann K, Wang W, Gitomer B, Strain JD, Schrier RW. Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2014;9:889\u201396.","journal-title":"Clin J Am Soc Nephrol"},{"key":"123_CR15","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","volume":"371","author":"RW Schrier","year":"2014","unstructured":"Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Bae KT, Moore CG, Chapman AB, Investigators H-PT. Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med. 2014;371:2255\u201366.","journal-title":"N Engl J Med"},{"key":"123_CR16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3904\/kjim.2015.30.1.17","volume":"30","author":"DC Jin","year":"2015","unstructured":"Jin DC. Major changes and improvements of dialysis therapy in Korea: review of end-stage renal disease registry. Korean J Intern Med. 2015;30:17\u201322.","journal-title":"Korean J Intern Med"},{"key":"123_CR17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.trre.2013.01.003","volume":"27","author":"SP McDonald","year":"2013","unstructured":"McDonald SP, Russ GR. Australian registries-ANZDATA and ANZOD. Transplant Rev. 2013;27:46\u20139.","journal-title":"Transplant Rev"},{"key":"123_CR18","first-page":"477","volume":"79","author":"F Davies","year":"1991","unstructured":"Davies F, Coles GA, Harper PS, Williams AJ, Evans C, Cochlin D. Polycystic kidney disease re-evaluated: a population-based study. Q J Med. 1991;79:477\u201385.","journal-title":"Q J Med"},{"key":"123_CR19","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1046\/j.1523-1755.2001.00758.x","volume":"59","author":"E Almeida de","year":"2001","unstructured":"de Almeida E, Sousa A, Pires C, Aniceto J, Barros S, Prata MM. Prevalence of autosomal-dominant polycystic kidney disease in Alentejo, Portugal. Kidney Int. 2001;59:2374.","journal-title":"Kidney Int"},{"key":"123_CR20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000045214","volume":"80","author":"E Higashihara","year":"1998","unstructured":"Higashihara E, Nutahara K, Kojima M, Tamakoshi A, Yoshiyuki O, Sakai H, Kurokawa K. Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan. Nephron. 1998;80:421\u20137.","journal-title":"Nephron"},{"key":"123_CR21","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ndt\/gfs551","volume":"28","author":"HP Neumann","year":"2013","unstructured":"Neumann HP, Jilg C, Bacher J, Nabulsi Z, Malinoc A, Hummel B, Hoffmann MM, Ortiz-Bruechle N, Glasker S, Pisarski P, Neeff H, Kramer-Guth A, Cybulla M, Hornberger M, Wilpert J, Funk L, Baumert J, Paatz D, Baumann D, Lahl M, Felten H, Hausberg M, Zerres K, Eng C, Else Kroener Fresenius AR. Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany. Nephrol Dial Transplant. 2013;28:1472\u201387.","journal-title":"Nephrol Dial Transplant"},{"key":"123_CR22","first-page":"123","volume":"17","author":"P Simon","year":"1996","unstructured":"Simon P, Le Goff JY, Ang KS, Charasse C, Le Cacheux P, Cam G. Epidemiologic data, clinical and prognostic features of autosomal dominant polycystic kidney disease in a French region. Nephrologie. 1996;17:123\u201330.","journal-title":"Nephrologie"},{"key":"123_CR23","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1093\/ndt\/12.10.2069","volume":"12","author":"C Yersin","year":"1997","unstructured":"Yersin C, Bovet P, Wauters JP, Schorderet DF, Pescia G, Paccaud F. Frequency and impact of autosomal dominant polycystic kidney disease in the Seychelles (Indian Ocean). Nephrol Dial Transplant. 1997;12:2069\u201374.","journal-title":"Nephrol Dial Transplant"},{"key":"123_CR24","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1053\/ajkd.2002.36943","volume":"40","author":"SP McDonald","year":"2002","unstructured":"McDonald SP, Russ GR, Kerr PG, Collins JF. Australia, New Zealand D, Transplant R: ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry. Am J Kidney Dis. 2002;40:1122\u201331.","journal-title":"Am J Kidney Dis"},{"key":"123_CR25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0272-6386(95)90096-9","volume":"25","author":"KW Florijn","year":"1995","unstructured":"Florijn KW, Noteboom WM, van Saase JL, Chang PC, Breuning MH, Vandenbroucke JP. A century of mortality in five large families with polycystic kidney disease. Am J Kidney Dis. 1995;25:370\u20134.","journal-title":"Am J Kidney Dis"},{"key":"123_CR26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1586\/erc.12.63","volume":"10","author":"BJ Epstein","year":"2012","unstructured":"Epstein BJ, Leonard PT, Shah NK. The evolving landscape of RAAS inhibition: from ACE inhibitors to ARBs, to DRIs and beyond. Expert Rev Cardiovasc Ther. 2012;10:713\u201325.","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"123_CR27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1136\/bmj.318.7178.234","volume":"318","author":"PA Kalra","year":"1999","unstructured":"Kalra PA, Kumwenda M, MacDowall P, Roland MO. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure. BMJ. 1999;318:234\u20137.","journal-title":"BMJ"},{"key":"123_CR28","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1093\/ndt\/13.12.3091","volume":"13","author":"V Schwenger","year":"1998","unstructured":"Schwenger V, Ritz E. Audit of antihypertensive treatment in patients with renal failure. Nephrol Dial Transplant. 1998;13:3091\u20135.","journal-title":"Nephrol Dial Transplant"},{"key":"123_CR29","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1440-1584.2012.01283.x","volume":"20","author":"LS Pilotto","year":"2012","unstructured":"Pilotto LS, Ball PA, Smithard JM, Kennedy DR. Electronic records suggest suboptimal management of chronic kidney disease in general practice. Aust J Rural Health. 2012;20:195\u20139.","journal-title":"Aust J Rural Health"},{"key":"123_CR30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/ki.2011.459","volume":"81","author":"B Orskov","year":"2012","unstructured":"Orskov B, Christensen KB, Feldt-Rasmussen B, Strandgaard S. Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease. Kidney Int. 2012;81:919\u201324.","journal-title":"Kidney Int"},{"key":"123_CR31","first-page":"925","volume":"34","author":"D Johnson","year":"2005","unstructured":"Johnson D, Usherwood T. Automated reporting of GFR--coming soon to a laboratory near you! Aust Fam Physician. 2005;34:925\u201331.","journal-title":"Aust Fam Physician"},{"key":"123_CR32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1093\/qjmed\/hct082","volume":"106","author":"KM Thong","year":"2013","unstructured":"Thong KM, Ong AC. The natural history of autosomal dominant polycystic kidney disease: 30-year experience from a single centre. QJM. 2013;106:639\u201346.","journal-title":"QJM"},{"key":"123_CR33","first-page":"212275","volume":"4","author":"CM Blanchette","year":"2015","unstructured":"Blanchette CM, Liang C, Lubeck DP, Newsome B, Rossetti S, Gu X, Gutierrez B, Lin ND. Progression of autosomal dominant kidney disease: measurement of the stage transitions of chronic kidney disease. Drugs Context. 2015;4:212275.","journal-title":"Drugs Context"},{"key":"123_CR34","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.ajkd.2012.08.038","volume":"61","author":"WE Boertien","year":"2013","unstructured":"Boertien WE, Meijer E, Li J, Bost JE, Struck J, Flessner MF, Gansevoort RT, Torres VE. Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease C: Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohort. Am J Kidney Dis. 2013;61:420\u20139.","journal-title":"Am J Kidney Dis"},{"key":"123_CR35","first-page":"491","volume":"99","author":"AN Graham","year":"1986","unstructured":"Graham AN, Neale TJ, Hatfield PJ, Morrison RB, Meech PR, Jacobson A, Faircloth C. Endstage renal failure due to polycystic kidney disease managed by continuous ambulatory peritoneal dialysis. N Z Med J. 1986;99:491\u20133.","journal-title":"N Z Med J"},{"key":"123_CR36","first-page":"84","volume":"5","author":"KB Modi","year":"1989","unstructured":"Modi KB, Grant AC, Garret A, Rodger RS. Indirect inguinal hernia in CAPD patients with polycystic kidney disease. Adv Perit Dial. 1989;5:84\u20136.","journal-title":"Adv Perit Dial"},{"key":"123_CR37","first-page":"832","volume":"9","author":"S Fletcher","year":"1994","unstructured":"Fletcher S, Turney JH, Brownjohn AM. Increased incidence of hydrothorax complicating peritoneal dialysis in patients with adult polycystic kidney disease. Nephrol Dial Transplant. 1994;9:832\u20133.","journal-title":"Nephrol Dial Transplant"},{"key":"123_CR38","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/ki.2008.352","volume":"74","author":"S Kumar","year":"2008","unstructured":"Kumar S, Fan SL, Raftery MJ, Yaqoob MM. Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis. Kidney Int. 2008;74:946\u201351.","journal-title":"Kidney Int"},{"key":"123_CR39","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1093\/ndt\/gfq712","volume":"26","author":"T Lobbedez","year":"2011","unstructured":"Lobbedez T, Touam M, Evans D, Ryckelynck JP, Knebelman B, Verger C. Peritoneal dialysis in polycystic kidney disease patients. Report from the French peritoneal dialysis registry (RDPLF). Nephrol Dial Transplant. 2011;26:2332\u20139.","journal-title":"Nephrol Dial Transplant"},{"key":"123_CR40","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/j.ajkd.2011.07.004","volume":"58","author":"JM Portoles","year":"2011","unstructured":"Portoles JM, Tato AM, Lopez-Sanchez P. Peritoneal dialysis for patients with polycystic kidney disease in Spain. Am J Kidney Dis. 2011;58:493\u20134.","journal-title":"Am J Kidney Dis"},{"key":"123_CR41","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1053\/j.ajkd.2011.01.019","volume":"57","author":"L Li","year":"2011","unstructured":"Li L, Szeto CC, Kwan BC, Chow KM, Leung CB, Kam-Tao Li P. Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2011;57:903\u20137.","journal-title":"Am J Kidney Dis"},{"key":"123_CR42","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/ckj\/sft171","volume":"7","author":"C Courivaud","year":"2014","unstructured":"Courivaud C, Roubiou C, Delabrousse E, Bresson-Vautrin C, Chalopin JM, Ducloux D. Polycystic kidney size and outcomes on peritoneal dialysis compared with haemodialysis. Clin Kidney J. 2014;7:138\u201343.","journal-title":"Clin Kidney J"},{"key":"123_CR43","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.arth.2013.07.048","volume":"29","author":"A Allepuz","year":"2014","unstructured":"Allepuz A, Martinez O, Tebe C, Nardi J, Portabella F, Espallargues M, Catalan Arthroplasty R. Joint registries as continuous surveillance systems: the experience of the Catalan Arthroplasty Register (RACat). J Arthroplasty. 2014;29:484\u201390.","journal-title":"J Arthroplasty"},{"key":"123_CR44","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000342620","volume":"2","author":"HP Neumann","year":"2012","unstructured":"Neumann HP, Malinoc A, Bacher J, Nabulsi Z, Ivanovas V, Bruechle NO, Mader I, Hoffmann MM, Riegler P, Kraemer-Guth A, Burchardi C, Schaeffner E, Martin RS, Azurmendi PJ, Zerres K, Jilg C, Eng C, Glasker S. Characteristics of intracranial aneurysms in the else kroner-fresenius registry of autosomal dominant polycystic kidney disease. Cerebrovasc Dis Extra. 2012;2:71\u20139.","journal-title":"Cerebrovasc Dis Extra"},{"key":"123_CR45","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/ndt\/gfr467","volume":"27","author":"B Orskov","year":"2012","unstructured":"Orskov B, Sorensen VR, Feldt-Rasmussen B, Strandgaard S. Changes in causes of death and risk of cancer in Danish patients with autosomal dominant polycystic kidney disease and end-stage renal disease. Nephrol Dial Transplant. 2012;27:1607\u201313.","journal-title":"Nephrol Dial Transplant"},{"key":"123_CR46","volume-title":"Polycystic kidney disease","author":"A Patil","year":"2015","unstructured":"Patil A, Sweeney Jr WE, Avner ED, Pan C. Childhood polycystic kidney disease. In: LI X, editor. Polycystic kidney disease. Brisbane: AU; 2015."},{"key":"123_CR47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.semnephrol.2015.10.004","volume":"35","author":"GK Rangan","year":"2015","unstructured":"Rangan GK, Lee VW, Alexander SI, Patel C, Tunnicliffe DJ, Vladica P. KHA-CARI autosomal dominant polycystic kidney disease guideline: screening for polycystic kidney disease. Semin Nephrol. 2015;35:557\u2013564 e556.","journal-title":"Semin Nephrol"},{"issue":"25","key":"123_CR48","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367(25):2407\u201318.","journal-title":"N Engl J Med"},{"key":"123_CR49","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00467-014-2882-8","volume":"30","author":"JJ Grantham","year":"2015","unstructured":"Grantham JJ. Rationale for early treatment of polycystic kidney disease. Pediatr Nephrol. 2015;30:1053\u201362.","journal-title":"Pediatr Nephrol"}],"container-title":["Population Health Metrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12963-017-0123-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T06:49:54Z","timestamp":1498373394000},"score":1,"resource":{"primary":{"URL":"http:\/\/pophealthmetrics.biomedcentral.com\/articles\/10.1186\/s12963-017-0123-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,17]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["123"],"URL":"https:\/\/doi.org\/10.1186\/s12963-017-0123-7","relation":{},"ISSN":["1478-7954"],"issn-type":[{"value":"1478-7954","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,17]]},"article-number":"7"}}